Blue Trust’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Blue Trust's LLY Position: Q3 2026 in Review
Blue Trust reduced its Eli Lilly (LLY) stake by 1.8% in Q3 2026, selling an estimated $1.61M and leaving 75,762 shares worth $87.7M. The position accounts for 0.92% of the portfolio, ranked #18.
Blue Trust first reported a position in LLY in Q2 2022 and has held it in 18 quarters since. The position peaked at $92.5M in Q2 2026. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Blue Trust held 75,762 shares of Eli Lilly worth $87.7M as of Q3 2026.
- Blue Trust sold 1,367 Eli Lilly shares in Q3 2026, an estimated $1.61M.
- Eli Lilly made up 0.92% of Blue Trust's portfolio in Q3 2026, its #18 holding.
- Blue Trust first reported a position in Eli Lilly in Q2 2022 and has held it in 18 quarters since.
- Blue Trust's Eli Lilly position peaked at $92.5M in Q2 2026.
- 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.